SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced that Brian S. Tyler,
Ph.D., has been appointed president and chief operating officer,
McKesson Corporation, effective August 2, 2018. Tyler will report to
John Hammergren, chairman and chief executive officer, and will become a
member of the executive committee.
“Brian is ideally suited to lead McKesson’s global operations based on
his deep industry knowledge, outstanding track record as a business
leader, and his commitment to operational excellence and customer
success,” said Hammergren. “His broad experience as the president of
multiple McKesson businesses provides him with the ideal background and
perspective to help lead McKesson’s strategic initiative and drive
long-term growth.”
Previously Chairman of the Management Board, McKesson Europe, Tyler has
also served as president of McKesson North American Pharmaceutical
Distribution and Services, McKesson U.S. Pharmaceutical, McKesson
Medical-Surgical and McKesson Specialty Health, as well as executive
vice president of corporate strategy and business development. His
direct reports will include:
-
President, McKesson U.S. Pharmaceutical and Specialty Health
-
President, McKesson Medical-Surgical
-
CEO, McKesson Canada
-
President, McKesson Prescription Technology Solutions (MRxTS)
-
President, Transformation Initiatives
-
Chairman, Management Board, McKesson Europe
“McKesson has outstanding products, services and solutions, and world
class talent,” said Tyler. “With these assets, the company is uniquely
positioned to drive innovation across the healthcare supply chain that
will improve value for our business partners and enable better, more
cost-effective patient care. I look forward to working with our
customers, manufacturing partners and McKesson’s more than 78,000
associates to deliver on that potential and accelerate McKesson’s
growth.”
Tyler earned his Ph.D. and M.A. from the University of Chicago,
Department of Economics in 1994, where he studied under a grant from the
National Science Foundation, and earned his B.A. in economics with high
honors from University of California Santa Cruz in 1989.
McKesson also announced today that Nick Loporcaro, president of
McKesson’s U.S. Pharmaceutical and Specialty Solutions segment, has
decided to leave McKesson to pursue other opportunities. Upon
Loporcaro’s departure on August 10, Tyler will lead this segment
directly until Loporcaro’s replacement has been named.
“Nick is a talented executive and we know he will accomplish great
things in his next chapter,” said Hammergren. “He has led McKesson
Canada, McKesson Specialty Health and most recently, the combined U.S.
Pharmaceutical and Specialty Health business. We thank him for his many
contributions to McKesson and wish him the greatest success.”
About McKesson Corporation
McKesson Corporation, currently ranked 6th on the FORTUNE
500, is a global leader in healthcare supply chain management solutions,
retail pharmacy, community oncology and specialty care, and healthcare
information technology. McKesson partners with pharmaceutical
manufacturers, providers, pharmacies, governments and other
organizations in healthcare to help provide the right medicines, medical
products and healthcare services to the right patients at the right
time, safely and cost-effectively. United by our ICARE shared
principles, our employees work every day to innovate and deliver
opportunities that make our customers and partners more successful — all
for the better health of patients. McKesson has been named the “Most
Admired Company” in the healthcare wholesaler category by FORTUNE, a
“Best
Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly
company by Military Friendly. For more information, visit www.mckesson.com.
